SCHEMBL7350490

SCHEMBL7350490

C=CCOC(=O)C(=O)C(N)CCC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.46
NFKB1 P19838 2/20 0.46
TSHR P16473 2/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
BLM P54132 1/20 0.46
SLC6A3 Q01959 1/20 0.46
MEN1 O00255 1/20 0.46
CYP2C19 P33261 1/20 0.46
KMT2A Q03164 1/20 0.46
GRM8 O00222 1/20 0.46
GRM6 O15303 1/20 0.46
GRIN2D O15399 1/20 0.46
GRIN3B O60391 1/20 0.46
GSR P00390 1/20 0.46
CYP1A2 P05177 1/20 0.46
GRIK1 P39086 1/20 0.46
GRM5 P41594 1/20 0.46
GRIA1 P42261 1/20 0.46
GRIA2 P42262 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29412215 0.87 BLM (0.44) CYP2D6NFKB1TSHRSLC6A2SLC6A4
SCHEMBL176230 0.84 CYP2D6 (0.50) CYP2D6NFKB1TSHRSLC6A2SLC6A4
SCHEMBL2518196 0.84 CYP2D6 (0.50) CYP2D6NFKB1TSHRSLC6A2SLC6A4
SCHEMBL27503400 0.79 SMN1; SMN2 (0.36) TSHRTDP1
SCHEMBL28743140 0.79 SMN1; SMN2 (0.36) TSHRTDP1
SCHEMBL27561734 0.79 SMN1; SMN2 (0.36) TSHRTDP1
SCHEMBL7205197 0.73 TSHR (0.46) CYP2D6NFKB1TSHRSLC6A2SLC6A4
SCHEMBL10609773 0.72 CYP1A2 (0.48) CYP2D6NFKB1TSHRSLC6A2SLC6A4
SCHEMBL666790 0.72 GRIK1 (0.48) TSHRSLC6A2SLC6A4BLMSLC6A3
SCHEMBL176228 0.72 GRIK1 (0.48) TSHRSLC6A2SLC6A4BLMSLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869967-A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME Vertex Pharmaceuticals Incorporated (US) 1998-10-14 EP disclosed
WO-1997022619-A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME VERTEX PHARMACEUTICALS INCORPORATED (US) 1997-06-26 WO disclosed